This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEBAG0BO_M.jpg
The U.S. online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.
GoodRx did not immediately respond to a request for comment.
